What You Should Know before Selecting a CRO

Events February 2, 2023

ACDM 2023

We are pleased to announce that we will be sponsoring and attending ACDM 2023. ACDM23 offers a full two-day program of expert speakers, specialist panels, workshops and debates which(...)

Clinical Data Science

Blog December 21, 2022

2022 Recap: Your Favorite Alira Health Publications

In 2022, the Alira Health team of scientists, strategists, economists, clinicians, and biostatisticians shared actionable insights, industry thought leadership, and leading-edge guidance(...)

Clinical Digital Health Market Access MedTech Pharma Regulatory

Blog December 14, 2022

How to Optimize Clinical Research with Patient Advisory Boards

Patient engagement is increasingly essential to all stages of product development—particularly clinical research.

Clinical Patient Advocacy Patient Centricity

Events November 30, 2022

Innovations in Wound Healing

We are excited to attend and sponsor a poster presentation at the Innovations in Wound Healing event this year. This unique meeting is led by a group of experienced educators, scientists(...)

Clinical Patient Centricity Wound Healing

Publications September 16, 2022

Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials

The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.

Biometrics Clinical eCOA

Blog September 7, 2022

The Promise and Reality of Decentralized and Hybrid Clinical Trials in Europe Today

To understand the challenges related to hybrid and decentralized trials and ways to overcome them, we spoke with Dr. Hervé Solatges, Product Management, Evidence, and Innovation (DCT(...)

Clinical Decentralized Clinical Trials Hybrid Clinical Trials

Blog September 5, 2022

Taking In-Licensed Biologics to Market: Challenges, Complexities, and Ways to Overcome Them

Taking a biologic through drug development to market is highly complex and filled with challenges. To understand these challenges, their implications and how to overcome them, we spoke(...)

Biologics Clinical Drug Development